Posters & Abstracts

ABSTRACT APPLICATIONS ARE NOW CLOSED 

Please check back in early 2023 for more information about next year's application process.

 


ABSTRACT TIMELINES

Participants interested in presenting data should submit abstracts online by September 19, 202211:59 PM ET. Abstracts are subject to acceptance by the Scientific Review Committee. Accepted abstracts will be published in the American Journal of Gastroenterology and accepted for poster display at the 2022 AIBD conference, December 5-7 in Orlando, Florida. Only abstracts received by the submission deadline will be published. Acceptance notifications will be sent on or before October 11, 2022.


ABSTRACT CATEGORIES

CLINICAL ABSTRACT CATEGORIES

C1. Outcomes Research
C2. Clinical Trials and IBD Therapies
C3. Procedures and Diagnostics
C4. Case Reports

NURSING/APP ABSTRACT CATEGORY 

N. Nurses/Advanced Practice Providers

PEDIATRIC CLINICAL ABSTRACT CATEGORY

P. Pediatrics

SURGICAL ABSTRACT CATEGORY 

S. Surgery

YOUNG INVESTIGATOR ABSTRACT CATEGORY 

Y. Young Investigator

 

ABSTRACT GUIDELINES

ACCEPTED FORMAT

  • Abstracts must be in English
  • 9-point Arial font
  • 500-word count limit
  • Use a concise title in title case only
  • List affiliations of author(s) as briefly as possible, with city, province/state, and country. The system can accommodate up to 20 total authors
  • Use standard and well-accepted abbreviations
  • When listing references, use standard and well-accepted formats
  • Abstract content should be single-spaced and typed in lower case
  • Abstracts shall be of original research and contain a concise statement of study aim
  • Please include the following four (4) parts of your abstract:
    • Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results "to be completed" and/or conclusions "to be discussed" are not acceptable
    • Incomplete abstracts will not be accepted


PREVIOUS PRESENTATION, PUBLICATION, AND DUPLICATION OF ABSTRACTS

  • Encore abstracts will be allowed if they contain new data. You will be prompted to submit the original abstract as reference
  • Abstracts will not be considered for presentation if they have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline
  • Abstracts will not be considered for presentation if they have been duplicated in any way
  • Abstracts may not be submitted to more than one category
  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and were not accepted for poster presentation, are eligible for submission but must contain new, additional information to be considered
  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author


POSTER ABSTRACT AWARDS

Abstracts are reviewed and accepted by the AIBD Scientific Review Committee. Each year the AIBD Scientific Review Committee recognizes the “Best Of” submitted abstracts. Winning abstracts receive free conference registration and a $500 scholarship to help off-set associated travel expenses. Abstract awards are given for the following categories: Clinical, Surgery, Pediatric, Nursing/APP, and Young Investigator.


COMMITMENT TO PRESENT

Submission of an abstract constitutes a commitment by the author(s) to 1) prepare an appropriately formatted abstract poster to showcase in the poster hall 2) be present in the poster hall onsite during receptions and session breaks to answer attendee questions, and 3) conduct an oral presentation live if selected as the winning abstract for the category (i.e., Best of Surgery Abstract). Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2022 Advances in IBD Conference.

The conference will withdraw abstracts upon written notification from the submitting author by October 15, 2022. If circumstances prevent onsite attendance, the primary author must arrange for the poster to be placed in the poster hall or presented by a co-author. 

AUTHORS
Industry authors can be a co-author, but they cannot be the lead and/or senior author.  Further, Industry authors cannot be the ones to present the research on site at AIBD.

*SPECIAL NOTE: 

Abstracts are Embargoed until 6 AM Monday, December 5.

Accepted poster abstracts are required to have author representation onsite in Florida during the meeting. All accepted abstracts will be published in the ACG Journal, and winning abstracts receive a $500 award stipend. 

**Fellows are also encouraged to apply for the Fellows Travel Grant, offering a $950 travel stipend. Up to 13 travel stipends will be awarded. Information on Fellows Travel Grant coming soon.

 

POSTER GUIDELINES

POSTER PRESENTATION DATES/TIME

Posters are to be displayed for the entirety of the Conference in the exhibit hall, December 5-7, 2022. Abstract authors will be able to address attendee questions live in the poster hall. 

Please check back soon for more details!
 

POSTER BOARD SIZE

4 feet tall x 6 feet wide
 

ONSITE POSTER SETUP

Please check in at Conference registration. Your poster must be displayed in the poster hall. Do not move your number or hang your poster in the place of another submission. Posters will be hung using push pins.
 

ONSITE POSTER BREAKDOWN

Please remove your poster at the conclusion of the Conference, by 11:00 AM on Thursday, December 8, 2021. Posters will be disposed of if not taken down by this time.
 

QUESTIONS?

For questions, please contact the administrator by email at IBD@owpm1.com

 

 

CONGRATULATIONS TO THE 2022 AWARD WINNERS!

Best of 2022 AIBD Abstract in Pediatrics
Changing Use of Biologic Medications and Associated Outcomes for Pediatric Inflammatory Bowel Disease
Jeremy Adler, MD

Best of 2022 AIBD Clinical Abstract from a Young Investigator
Development of an Artificial Intelligence Tool for Detection of Polypoid Lesions in Inflammatory Bowel Disease (IBD-CADe)
Daniela Guerrero Vinsard, MD

Best of 2022 AIBD Abstract in Surgery
Transanal Ileal Pouch-anal Anastomosis for Inflammatory Bowel Disease (ta-IPAA): A Systematic Review and Meta-analysis
Eddy Lincango, MD

Best of 2022 AIBD Clinical Abstract
Venous Thromboembolism Risk in Hospitalized Tofacitinib-Exposed Patients: A Real-World Experience of 533 Patients
Megan Obi, MD